Orange Book product · Generic (ANDA)
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
At a glance
Dec 09, 2025
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 09, 2025
6 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXYCYCLINE HYCLATE
Strength
EQ 100MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 211137
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DOXYCYCLINE HYCLATE
- 2016ACTICLATE CAPBrand (NDA)
NDA 208253 · CHARTWELL RX
- 2001DORYXBrand (NDA)
NDA 050582 · MAYNE PHARMA
- 1998PERIOSTATBrand (NDA)
NDA 050744 · COLLAGENEX
- —VIBRAMYCINBrand (NDA)
NDA 050007 · PFIZER
- 2026DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 203276 · AVET LIFESCIENCES
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 218888 · ASPIRO
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 218753 · DR REDDYS
- 2025DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217078 · PRECISION DOSE INC
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217487 · AMNEAL
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 218053 · KINDOS
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217854 · HERITAGE
- 2024DOXYCYCLINE HYCLATEGeneric (ANDA)
ANDA 217794 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
